DRDATSONS

Religare Finvest Limited has submitted to the Exchange, vide letter dated January 28, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated January 29, 2014 a copy of Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated January 28, 2014 a copy of Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Bakulesh T Shah has submitted to the Exchange vide letter dated January 27, 2014 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Datson's Labs Limited has submitted to the Exchange vide letter dated January 27, 2014 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated June 29, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide letter dated June 19, 2013 a copy of Disclosure under Regulation 13(4), 13(6) and 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated June 19, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, along with a copy of disclosure pursuant to Regulation 13(4) and 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has submitted to the Exchange vide letter dated May 28, 2013 a copy of Disclosure under Regulation 13(4), 13(6) and 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated May 28, 2013 a copy of Disclosure under Regulation 13(4), 13(6) and 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated May 02, 2013 a copy of Disclosure under Regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has submitted to the Exchange Vide its letter dated April 17, 2013 a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of (Prohibition of Insider Trading) Regulation, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated April 17, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011,along with a copy of disclosure pursuant to Regulation 13(4) and13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992..

Finaventure Capital Limited has submitted to the Exchange vide letter dated April 17, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of (Prohibition of Insider Trading) Regulation, 1992.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of Disclosure, in respect of details of shares under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Bakulesh T. Shah has submitted to the Exchange vide letter dated April 12, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated April 09, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011,along with a copy of disclosure pursuant to Regulation 13(4) and13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992..

Finaventure Capital Limited has submitted to the Exchange vide letter dated April 09, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide letter dated April 01, 2013 a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated April 01, 2013 a copy of disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4) and13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated March 20, 2013 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 20, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide letter dated March 20, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 12, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 11, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 04, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 02, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 20, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated February 26, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated March 02, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated February 26, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange vide its letter dated March 02, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Aanjaneya Lifecare Limited has submitted to the Exchange vide its letter dated February 26, 2013 a copy of disclosure under Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide its letter dated February 01, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide its letter dated January 31, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Aanjaneya Lifecare Limited has submitted to the Exchange a copy of Disclosures, in respect of details of shares under Regulation 13(6) of SEBI (Prohibition of Insider Trading regulations). 1992.

Kannan Vishwanath has submitted to the Exchange vide its letter dated January 22, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated January 18, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated January 04, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated January 01, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Limited has submitted to the Exchange vide letter dated December 28, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Finaventure Capital Limited has submitted to the Exchange vide letter dated December 14, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 .

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 21, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr. Kannan Vishwanath has submitted to the Exchange vide letter dated December 18, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 19, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Kannan Vishwanath has submitted to the Exchange vide letter dated December 14, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 34850 shares.

Kannan Vishwanath has submitted to the Exchange vide letter dated December 12, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for acquisition of 12000 shares.

Finaventure Capital Ltd has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dr.Kannan Vishwanath has submitted to the Exchange vide letter dated December 10, 2012 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.